Login to Your Account



Genentech Hits Home Run With Anti-Angiogenesis Cancer Trial

By Brady Hugget


Tuesday, May 20, 2003
Bullish on biotech in '03. That's the take on the industry by Banc of America Securities, a viewpoint it attributes to a season of earnings re-acceleration and late-stage data, prompting the firm to label 2003 as potentially "the biggest product year ever for biotech." (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription